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The effects of multiple doses of estradiol dipropionate (EDP) or
calcium glucoheptonate (Ca) on the growth and function of pituitary
somatotropes (GH cells) were studied. Female middle-aged rats were
receiving i.p. EDP (0.625 mg i.p./kg b.w.), or Ca (11.4 mg/kg b.w) every
day for two weeks. Blood samples were collected for hormone
analyses and pituitaries dissected for histological and morphometric
evaluation 24 h after the last injection. GH-producing cells were
examined using the peroxidase-antiperoxidase (PAP) immuno-
histochemical procedure. Both EDP- and Ca-treatment significantly
decreased all morphometric parameters of GH cells (p<0.05) in
comparison with the corresponding controls. Serum concentration of
growth hormone (GH) in EDP- or Ca-treated groups was lower by 65%
and 13% (p<0.05) respectively, comparing to the controls. The
difference between all morphometric parameters of EDP- and Ca-
treated rats was statistically significant (p<0.05) in relation to the
controls. These findings suggest that multiple EDP, or Ca application
affects (directly or indirectly) the control of growth and secretory activity
of GH cells in middle-aged female rats.
Key words: estradiol, GH cells, growth hormone, middle aged,
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INTRODUCTION
Middle-age (8-11 months old) and ageing (16-18 months old) are critical
periods for the control of growth hormone (GH) and somatostatin gene
expression in higher animals of both sexes (Wise and Camp 1984, Martinoli et al.
1991). Ageing is a biological process, that includes alterations of the humoral
regulatory system in which the hypothalamo-pituitary axis plays an important role.
Some of the hormones secreted from the anterior pituitary are related to the
potency of survial during ageing (Ooka 1993). Age-related changes in hormonal
secretion can also be secondary to physiological changes in circadian and
seasonal rhythms, or in the frequency or height of hormonal pulses (Mooradian
1993). Plasma growth hormone (GH) secretion was found to be gradually
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decreasing from maturity and middle-age (8-15 months of age) in rats of both
sexes (Sonntag et al. 1982, Mobbs 1996). Takahashi (1992) reported an increase
of somatostain release and a decrease in growth hormone-releasing hormone
(GHRH), associated with a reduction of hypothalamic catecholamine activity in
middle-aged rats. The amplitude of GH pulses was also reduced in middle-aged
and old rats, but not the values or intervals between each pulse, which averaged
about 6 min (Takahashi et al. 1987).
In the rat's pituitary pars distalis the nuclear concentration of estradiol was
observed in all cell types including acidophils, basophils and chromophobes.
More specifically, localization of estradiol is not confined to gonadotropes but
occurs also with a decreasing intensity in somatotropic, lactotropic and
thyreotropic cells (GH, PRL and TSH cells, respectively) (Keefer 1981). Friend et
al. (1997) identified several estrogen mRNA isoforms in the rat's pituitary and
characterized their regulation by gonadal steroids. Takahashi (1992) also showed
that estrogens acted by decreasing the percentage of GH cells in rats of both
sexes.
In addition to hormones, secretory processes in the anterior pituitary cells
are controlled by regulatory molecules such as Ca2+ ions, vitamins, metabolites
and growth factors (Perez et al. 1995). Calcium is an essential nutrient involved in
most metabolic processes and calcium phosphate salts provide mechanical
rigidity to the bones and teeth, where 99% of body's calcium resides (Nordin
1997). Thus, the consequences of calcium deficiency include not only
osteoporosis, but also arteriosclerosis, hypertension, senile dementia and
disturbances in cellular functions (Fujita 1985). Hence, calcium supplements that
guarantee an adequate supply of this essential mineral in perimenopausal and
postmenopausal women are widely applied (Avioli 1984).
The above facts prompted us to examine the characteristics of
immunoreactive GH cells in the pituitary of middle-aged female rats multiple
treated with estradiol dipropionate (EDP) or Ca-glucoheptonate. For this purpose
histological, sterological and biochemical methods were employed.
MATERIAL AND METHODS
Animals. Wistar 14-month-old female rats, bred at the Institute for Biological
Research, Belgrade, were used. Middle-aged female rats were i.p. receiving
estradiol dipropionate (EDP; 0.625 mg i.p./kg b.w.), or calcium glucoheptonate
(Ca; 11.4 mg/kg b. w) every day for two weeks. The animals were kept under a
12:12 h light-dark cycle, at 22±2 oC. They had free access to food (a product of
Veterinarski zavod Subotica, Subotica, Serbia and Montenegro) and water.
Cytological examinations of vaginal smears started at 13 months of age. The
oestrous cycle of these females was irregular with long oestrus stages (persistent
vaginal cornification) interspaced by one or two days of proestrus or diestrus.
Light microscopy and immunocytochemistry. Pituitary glands were excised,
fixed in Bouin’s solution for 48 h and embedded in paraffin. Tissue sections 5 m
thick were deparaffinized in xylol and alcohol. Pituitary hormones were localized
by the peroxidase-antiperoxidase-complex (PAP) method of Sternberger et al.
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(1970). Endogenous peroxidase activity was blocked by incubation in 9 mmol/L
hydrogen peroxide in methanol for 30 min at room temperature. Before the
application of specific primary antisera, non-specific background staining was
minimized by incubating the sections with non-immune, porcine serum diluted
with phosphate buffered saline, pH 7.4 (PBS) for 60 min. The sections were then
overlaid with the appropriate dilutions of the specific primary antibodies (hGH-
antisera, "Dako A/S", Glostrup, Denmark) for 24 h at 4 oC. After washing in PBS,
the sections were incubated for another 60 min with the second antibody swine-
antirabbit IgG for 45 min, rinsed again with PBS for 10 min and incubated with
rabbit PAP serum for 45 min. The localization of antibodies was visualized by
incubating the sections in Tris-HCl buffered saline (0.05 mol/L, pH 7.4)
supplemented with 3,3-diaminobenzidine tetrachloride (DAB) (Serva, Heidelberg,
Germany) and 9 mmol/L hydrogen peroxide. The slides were thoroughly washed
under running tap water, counterstained with haematoxylin and mounted in
Canada balsam ("Alkaliod", Skopje, FYR Macedonia). Control sections were
incubated without primary antisera or by substituting non-immune rabbit serum
for the primary antiserum.
Morphometry. Measurements were performed on the widest portion of the
pituitary gland and immunocytochemically labelled GH cells were analyzed by the
M42 test system (Weibel, 1979). For the calculations of cellular and nuclear
volumes, the formula of Weibel (1979) was used.
Hormone assay. Serum concentrations of GH in the control and treated rats
were measured by Delfia method (hGH-Delfia kits, LKB, Turky, Finland).
Statistical analyses. Biochemical and morphometric data obtained for each
group were averaged and the standard deviation of the mean was calculated. A
one-way analysis of variance (ANOVA), followed by the multiple range test of
Duncan (Pharmacological Calculation System, 1986) was used for statistical
comparisons of the differences between the groups. A probability value of 5% or
less was considered statistically significant.
RESULTS
In female rats, treated with either EDP or Ca-glucoheptonate the body
weight was significantly decreased (p<0.05) in comparison with the controls.
However, the absolute and relative pituitary weights in each of the treated groups
were significantly increased (p<0.05) in comparison with the corresponding
controls (Table 1).
Immunocytochemically identified GH cells in the control rat's pituitaries
were ovoid to pyramidal in shape, with a spherical centrally located nucleus. GH
cells were usually situated along sinusoids (Fig. 1a). In either estradiol- or Ca-
treated pituitaries, GH cells were smaller, irregularly shaped, with more intensely
stained secretory granules (Figs. 1b, 1c) and dilated blood capillaries (Fig. 1b).
Morphometric studies revealed a significant decrease in the number and
volume densities of perikarya (Fig. 2) of somatotropic cells in all treated rat
females. Relative volume density of these cells was decreased by 86% and 21%,
in EDP- and Ca-treated group, respectively, in comparison with the controls the
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difference was statistically significant. An extremely striking difference in all
morphometric parameters measured in the present study was observed in EDP-
treated animals.
Table 1. The effect of multiple EDP or Ca-glucoheptonate treatment on body weight,
absolute and relative pituitary weight of middle-aged rat females
Experimental group
Body weight
(g)
Absolute pituitary
weight (mg)
Relative pituitary
weight (mg/%)
Control 336 ± 7.0 17.3 ± 0.8 5.3 ± 0.3
EDP
307 ± 4.0*
(–9%)
36.4 ± 5.4*
(+110%)
11.8 ± 1.6*
(+123%)
Ca
306 ± 1.0*
(–9%)
30.5 ± 3.5*
(+76%)
7.4 ± 0.8*
(+40%)
The given values are for mean ±S.E.M.; *p<0.05
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Figure 1. Immunohistochemically labelled GH cells (arrows) in: a) controls, b) EDP-treated
rats and c) Ca2+_ treated rats. (PAP; X 1256)
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Figure 2. A) Cellular volume (Vc; m3) of the immunoreactive GH cells B) Nuclear volume
(Vn; m3) of GH cells; C) Relative volume density (Vv; %) of GH cells expressed as
percentages of total glandular tissue. The values are the means ± S.D.
(n=5/group), ap<0.05 vs. control
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The serum concentration of GH was also significantly decreased in EDP-
and Ca-treated rats (by 65% and 13%, respectively; p<0.05) in comparison with
the controls (Fig. 3).
DISCUSSION
Ageing is associated with a myriad of hormonal and anatomical changes of
the endocrine glands, notably as a result of programmed cell death, autoimmune-
mediated destruction of the gland, or neoplastic transformation of granular tissue
(Mooradian, 1993). The mechanisms underlying these changes are variable. In a
previous study, we have observed a reduction of pituitary TSH- (Sekuli} et al.
1998) and gonadotrophic- (FSH and LH; Lovren et al. 1999) cell activity in middle-
aged rats. In middle-aged rats the structure and function of C cells was also
reduced.
The results obtained throughout the present study clearly demonstrate that
multiple EDP doses given to middle-aged female rats resulted in an increase of
absolute and relative pituitary weight. This could be explained by an increased
number of chromophobe prolactin (PRL) cells (Panti}, 1980, 1995; Lovren and
Sekuli} 1994) and ACTH cells (Kosti} et al., 2003). Takahashi and Kawashima
(1987) observed a significant age-related increase of the DNA content in PRL cells
in rats of both sexes, but this increase was more conspicuous in females than in
males, suggesting a significant increase in the number of PRL cells, as well as in
PRL secretion.
Results demonstrate that pituitary GH cells of middle-aged female rats
responded to multiple treatment with either EDP or Ca-glucoheptonate. This is
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Figure 3. Serum concentration of growth hormone in Wistar female rats treated with EDP or
Ca-glucoheptonate. Data are expressed as the means ±S.D.
(n=5/group; *p<0.05 vs. control
supported by the values of measured morphometric parameters. Relative volume
density of GH cells and volume of the perikarya were significantly lower in both
treated groups in comparison with the corresponding controls. Average blood
serum GH concentration was also decreased after multiple doses of either EDP or
Ca-glucoheptonate.
An extremely striking difference in all measured parameters was observed
in EDP-treated animals. As early as in 1982, Sontag et al. observed that the GH
secretion in rats was declining with age. On the other hand, several authors
examined the cause of a decreased pituitary GH content with ageing in rats
(Takahashi 1992, Mobbs 1996). Serum GH levels in young female rats were found
to be significantly higher than those of middle-aged animals (Takahashi et al.
1987). This decrease of serum GH level observed in middle-aged female rats was
interpreted to be partly due to an increase in somatostatin release from the
hypothalamus (Takahashi et al. 1987), a decrease in GHRH release, as well as a
reduced pituitary responsiveness to GHRH stimulation (Panti} 1980). The
amplitude of GH pulsatile release was also lower in middle-aged than in young
rats (Takahashi et al.1987). Shibasaki et al. (1984) observed an age-related
decrease in growth hormone (GH) responsiveness to growth hormone-releasing
hormone (GHRH) and somewhat later, Abribat et al. (1991) reported a reduced
pituitary adenylate cyclase response to altered GHRH binding sites of the pituitary
gland. Morphologically classified growth hormone cell populations, changed in
accordance with the GH secretory activity. Thus, it is highly probable that
morphological heterogeneity of GH cells reflects functional heterogeneity and/or
the maturation process of these cells (Kurosumi et al. 1986). Estrogens were
shown to inhibit GH secretion and to reduce growth hormone-releasing hormone
(GHRH) (Panti} 1980). Takahashi (1992) demonstrated that estrogen acted
increasing the percentage of GH cells of Type II and Type III. Type II GH cells
contain large and small secretory granules (100-150 nm in diameter), while cells
of type III contain small secretory granules. Age-related decrease in the number of
estrogen receptors of the pituitary (Mooradian 1993) or impaired nuclear binding
to the receptors (Belisle et al. 1990) were shown to be associated with a
decreased uterine responsiveness to estrogens.
In the present study, we observed that multiple treatment of middle-aged
female rats with Ca resulted in a decrease of all measured morphometric
parameters of GH cells, as well as of the blood serum GH level. Calcium is known
as an essential nutrient involved in a number of metabolic processes and its
phosphate salts provide mechanical rigidity to bones and teeth, where 99% of
body's calcium occurs (Nordin 1997). Calcium also controls numerous cell
functions in general, including pituitary cells. Zorec (1996) reported that a rise in
cytosolic Ca2+ ions represents an important trigger for hormone secretion from
pituitary cells. In our earlier studies we have shown that chronic treatment of
middle-aged female rats acted reducing morphofunctional characteristics of
gonadotrophic and TSH cells (Sekuli} et al., 1998; Lovren et al., 1999).
Based on results the presented results and the data of other authors, it can
be concluded that multiple application of EDP and Ca to middle-aged female rats
results in a suppression of morphofunctional characteristics of pituitary GH cells.
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However, the observed decrease of immunocytochemical and morphometric
parameters was much more pronounced in the EDP-treated group than in Ca-
treated group of experimental animals.
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DELOVANJE ESTRADIOLA I KALCIJUMA NA ]ELIJE HIPOFIZE KOJE LU^E
HORMON RASTA U ACIKLI^NIH @ENKI PACOVA
MILO[EVI] VERICA, TRIFUNOVI] SVETLANA, [O[I]-JURJEVI] BRANKA,
BUJ[I] NADA i SEKULI] MILKA
SADR@AJ
Ispitivani su efekti vi{ekratnih doza estradiol dipropionata (EDP) ili kalcijum
glukoheptonata (Ca) na rast i funkciju hipofiznih }elija hormona rasta (GH)
acikli~nih `enki Wistar pacova. Acikli~ne `enke su svakodnevno tokom dve
nedelje i.p. dobijale 0.625 mg EDP/kg t.m., ili 11.4 mg Ca/kg t.m.. Krv je sakuplja-
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na radi odre|ivanja koncentracije hormona rasta u serumu, a hipofize su pripre-
mane za histolo{ku i morfometrijsku analizu. GH }elije su imunocitohemijski
obele`avane metodom peroksidaza-antiperoksidaza (PAP). Morfometrijski para-
metri su bili zna~ajno smanjeni (p<0.05) u `ivotinja tretiranih EDP-om, ili kalciju-
mom u pore|enju sa odgovaraju}im kontrolama. Koncentracija hormona rasta u
serumu bila je tako|e zna~ajno ni`a (p<0.05) u obe tretirane grupe (za 65% od-
nosno za 13%) u pore|enju sa odgovaraju}om kontrolom. Dobijeni rezultati uka-
zuju da vi{ekratni tretman acikli~nih `enki pacova EDP-om ili Ca-glukohepto-
natom deluje inhibitorno na GH }elije i da su i estrogeni i kalcijum uklju~eni na
specifi~an na~in u rast i sekretornu aktivnost GH }elija hipofize.
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